CTLA4 gene and autoimmune endocrinopathies: A new marker?

Journal of Endocrinological Investigation

Volumn 25, Issue 11, 2002, Pages 1001-1005

  Pociot, Flemming ^a  

^a STENO DIABETES CENTER   (Denmark)

Author keywords

CTLA4 gene

Indexed keywords

ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INTERLEUKIN 2; INTERLEUKIN 4; TELOMERASE;

3' UNTRANSLATED REGION; ANTIGEN EXPRESSION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CHROMOSOME 1; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; ENDOCRINE DISEASE; ENVIRONMENTAL FACTOR; EXON; GENE MAPPING; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC DATABASE; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENOTYPE; HELPER CELL; HUMAN; IMMUNE COMPLEX DISEASE; IMMUNE RESPONSE; IMMUNE SYSTEM; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTIC INFILTRATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULE; MULTIFACTORIAL GENETIC DISORDER; NONHUMAN; PATHOLOGY; PHENOTYPE; REVIEW; RISK FACTOR; T LYMPHOCYTE ACTIVATION;

EID: 0036961410     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03344076     Document Type: Review

References (18)

1. Kristiansen O.P., Larsen Z.M., Pociot F. CTLA-4 in autoimmune diseases - A general susceptibility gene to autoimmunity? Genes Immun. 2000, 1: 170-184.
2. Dong C., Jeudes A.E., Temann U.A. et al. ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature 2001, 409: 97-101.
3. Tafuri A., Shahinian A., Bladt F. et al. ICOS is essential for effective T-helper-cell responses. Nature 2001, 409: 105-109.
4. Lenschow D.J., Walunas T.L., Bluestone J.A. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 1996, 14: 233-258.
5. Walunas T.L., Lenschow D.J., Bakker C.Y. et al. Ctla-4 can function as a negative regulator of t-cell activation. Immunity 1994; 1: 405-413.
6. Waterhouse P., Penninger J.M., Timms E. et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 1995; 270: 985-988.
7. Tivol E.A., Borriello F., Schweitzer A.N., Lynch W.P., Bluestone J.A., Sharpe A.H. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995, 35: 541-547.
8. Takashi T., Tagami T., Yamazaki S. et al. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 2000; 192: 303-310.
9. Nisticò L., Buzzetti R., Pritchard L.E. et al. The ctla-4 gene region of chromosome 2q33 is linked to, and associated with, type-1 diabetes. Hum. Mol. Genet. 1996; 5: 1075-1080.
10. Deichmann K., Heinzmann A., Brüggenolte E., Forster J., Kuehr J. An Mse I RFLP in the human CTLA4 promotor. Biochem. Biophys. Res. Commun. 1996, 225: 817-818.
11. Larsen Z., Kristiansen O.P., Mato E. et al. IDDM12 (CTLA4) and IDDM13 on 2q34 in genetic susceptibility to Type 1 diabetes (insulin-dependent). Autoimmunity 1999, 31: 35-42.
12. Djilali-Saiah I., Ouellette P., Caillat-Zucman S., Debray D., Kohn J.I., Alvarez F. CTLA-4/CD 28 region polymorphisms in children from families with autoimmune hepatitis. Hum. Immunol. 2001, 62: 1356-1362.
13. Pociot F. (ed.), CTLA-4 in Autoimmune Diseases. Georgetown, TX, Landes Bioscience 2002.
14. Kouki T., Sawai Y., Gardine C.A., Fisfalen M.E., Alegre M.L., DeGroot L.J. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J. Immunol. 2000, 165: 6606-6611.
15. Huang D., Giscombe R., Zhou Y., Pirskanen R., Lefvert A.K. Dinucleotide repeat expansion in the CTLA-4 gene leads to T cell hyper-reactivity via the CD28 pathway in myasthenia gravis. J. Neuroimmunol. 2000, 105: 69-77.
16. Shaw G., Kamen R. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 1986, 46: 659-667.
17. Yanagawa T., Hidaka Y., Guimaraes V., Soliman M., Degroot L.J. Ctla-4 gene polymorphism associated with graves-disease in a caucasian population. J. Clin. Endocrinol. Metab. 1995, 80: 41-45.
18. Johnson G.C.L., Esposito L., Barratt B.J. et al. Haplotype tagging for the identification of common disease genes. Nature Genet. 2001, 29: 233-237.